205 related articles for article (PubMed ID: 26379390)
1. International guidelines for the management of pancreatic intraductal papillary mucinous neoplasms.
Goh BK
World J Gastroenterol; 2015 Sep; 21(34):9833-7. PubMed ID: 26379390
[TBL] [Abstract][Full Text] [Related]
2. Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer.
Nguyen AH; Toste PA; Farrell JJ; Clerkin BM; Williams J; Muthusamy VR; Watson RR; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
J Gastrointest Surg; 2015 Feb; 19(2):258-65. PubMed ID: 25373706
[TBL] [Abstract][Full Text] [Related]
3. Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size.
Han Y; Lee H; Kang JS; Kim JR; Kim HS; Lee JM; Lee KB; Kwon W; Kim SW; Jang JY
Gastroenterology; 2018 Feb; 154(3):576-584. PubMed ID: 29074452
[TBL] [Abstract][Full Text] [Related]
4. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis.
Crippa S; Bassi C; Salvia R; Malleo G; Marchegiani G; Rebours V; Levy P; Partelli S; Suleiman SL; Banks PA; Ahmed N; Chari ST; Fernández-Del Castillo C; Falconi M
Gut; 2017 Mar; 66(3):495-506. PubMed ID: 26743012
[TBL] [Abstract][Full Text] [Related]
5. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series.
Sahora K; Mino-Kenudson M; Brugge W; Thayer SP; Ferrone CR; Sahani D; Pitman MB; Warshaw AL; Lillemoe KD; Fernandez-del Castillo CF
Ann Surg; 2013 Sep; 258(3):466-75. PubMed ID: 24022439
[TBL] [Abstract][Full Text] [Related]
6. Utility of the sendai consensus guidelines for branch-duct intraductal papillary mucinous neoplasms: a systematic review.
Goh BK; Tan DM; Ho MM; Lim TK; Chung AY; Ooi LL
J Gastrointest Surg; 2014 Jul; 18(7):1350-7. PubMed ID: 24668367
[TBL] [Abstract][Full Text] [Related]
7. Survival Analysis and Risk for Progression of Intraductal Papillary Mucinous Neoplasia of the Pancreas (IPMN) Under Surveillance: A Single-Institution Experience.
Del Chiaro M; Ateeb Z; Hansson MR; Rangelova E; Segersvärd R; Kartalis N; Ansorge C; Löhr MJ; Arnelo U; Verbeke C
Ann Surg Oncol; 2017 Apr; 24(4):1120-1126. PubMed ID: 27822633
[TBL] [Abstract][Full Text] [Related]
8. Patterns of recurrence and long-term outcomes in patients who underwent pancreatectomy for intraductal papillary mucinous neoplasms with high grade dysplasia: implications for surveillance and future management guidelines.
Blackham AU; Doepker MP; Centeno BA; Springett G; Pimiento JM; Malafa M; Hodul PJ
HPB (Oxford); 2017 Jul; 19(7):603-610. PubMed ID: 28495434
[TBL] [Abstract][Full Text] [Related]
9. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.
Tanaka M; Chari S; Adsay V; Fernandez-del Castillo C; Falconi M; Shimizu M; Yamaguchi K; Yamao K; Matsuno S;
Pancreatology; 2006; 6(1-2):17-32. PubMed ID: 16327281
[TBL] [Abstract][Full Text] [Related]
10. Patients with a resected pancreatic mucinous cystic neoplasm have a better prognosis than patients with an intraductal papillary mucinous neoplasm: A large single institution series.
Griffin JF; Page AJ; Samaha GJ; Christopher A; Bhaijee F; Pezhouh MK; Peters NA; Hruban RH; He J; Makary MA; Lennon AM; Cameron JL; Wolfgang CL; Weiss MJ
Pancreatology; 2017; 17(3):490-496. PubMed ID: 28416122
[TBL] [Abstract][Full Text] [Related]
11. The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines.
Watanabe Y; Endo S; Nishihara K; Ueda K; Mine M; Tamiya S; Nakano T; Tanaka M
Surg Today; 2018 Nov; 48(11):1011-1019. PubMed ID: 29961172
[TBL] [Abstract][Full Text] [Related]
12. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
[TBL] [Abstract][Full Text] [Related]
13. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas.
Bae SY; Lee KT; Lee JH; Lee JK; Lee KH; Rhee JC
Dig Liver Dis; 2012 Mar; 44(3):257-60. PubMed ID: 22030480
[TBL] [Abstract][Full Text] [Related]
14. "Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation?
Marchegiani G; Andrianello S; Pollini T; Caravati A; Biancotto M; Secchettin E; Bonamini D; Malleo G; Bassi C; Salvia R
Am J Gastroenterol; 2019 Oct; 114(10):1678-1684. PubMed ID: 31449158
[TBL] [Abstract][Full Text] [Related]
15. Uptodate in the assessment and management of intraductal papillary mucinous neoplasms of the pancreas.
Pagliari D; Saviano A; Serricchio ML; Dal Lago AA; Brizi MG; Lanza F; Manfredi R; Gasbarrini A; Attili F
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2858-2874. PubMed ID: 28682431
[TBL] [Abstract][Full Text] [Related]
16. Validation of the clinical utility of 4 guidelines in the initial triage of mucinous cystic lesions of the pancreas based on cross-sectional imaging: Experience with 188 surgically-treated patients.
Park RHS; Lim GRS; Wu JJY; Koh YX; Teo JY; Cheow PC; Chan CY; Ooi LLPJ; Chung AYF; Goh BKP
Eur J Surg Oncol; 2020 Nov; 46(11):2114-2121. PubMed ID: 32828582
[TBL] [Abstract][Full Text] [Related]
17. One of the multifocal intraductal papillary mucinous neoplasms with the clinical characteristics of mucinous cystic neoplasm.
Hata T; Sakata N; Motoi F; Unno M
BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23420728
[TBL] [Abstract][Full Text] [Related]
18. Are the Sendai and Fukuoka consensus guidelines for cystic mucinous neoplasms of the pancreas useful in the initial triage of all suspected pancreatic cystic neoplasms? A single-institution experience with 317 surgically-treated patients.
Goh BK; Tan DM; Thng CH; Lee SY; Low AS; Chan CY; Wong JS; Lee VT; Cheow PC; Chow PK; Chung AY; Wong WK; Ooi LL
Ann Surg Oncol; 2014 Jun; 21(6):1919-26. PubMed ID: 24504924
[TBL] [Abstract][Full Text] [Related]
19. Outcome of long interval radiological surveillance of side branch pancreatic duct-involved intraductal papillary mucinous neoplasm in selected patients.
Khaled YS; Mohsin M; Fatania K; Yee A; Adair R; Sheridan M; Macutkiewicz C; Aldouri A; Smith AM
HPB (Oxford); 2016 Nov; 18(11):879-885. PubMed ID: 27591177
[TBL] [Abstract][Full Text] [Related]
20. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients.
Roch AM; DeWitt JM; Al-Haddad MA; Schmidt CM; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
J Am Coll Surg; 2014 Jul; 219(1):122-9. PubMed ID: 24862887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
